Pharmaceutical Commerce
CONTINUE TO SITE >

OR WAIT 15 SECS

Pharmaceutical Commerce - May/June 2012

Navigating the tense, complex oncology market

June 12, 2012

Oncology combines some of the most life-changing therapeutic events with the most complex commercialization pathways. Rising costs of treatments simply add to the tension

2012 site selection report

June 01, 2012

Biopharma remains a bright spot in US and international economic activity, even while the overall outlook remains cloudy

Healthcare's 'third place--patient-centered healthcare--is life sciences' future business focus, says E&Y

May 30, 2012

Latest annual Progressions report highlights the shift to healthy behaviors

Supply chains for a patient-centric world

May 30, 2012

Tomorrow's healthcare market, driven by consumer choice and outcomes-driven economics, will create new supply chain models

FTC Approves Express Scripts/Medco Merger: Excerpts

May 30, 2012

Merger is not expected to affect specialty-distribution agreements negatively

Jobs and biopharma

May 30, 2012

Ten-year BLS projection sees a healthy industry ahead

US market for pharmaceuticals was $320 billion in 2011, says IMS Institute

May 30, 2012

Patient office visits, prescription usage continued to decline

NEHI: Medication adherence needs better coordination among stakeholders

May 30, 2012

Pharma industry serves best as underwriter of healthcare providers' efforts

Some good news on drug shortage--finally

May 30, 2012

Covis Pharmaceuticals' business model is to acquire distribution rights to low-volume drugs

A scientific approach to site selection

May 30, 2012

Applying a consistent framework to choose locations can help optimize R&D and drive cost reduction for pharmaceutical companies of all sizes

Compliance, technology energize the master-data management business

May 01, 2012

Compiling and maintaining lists of healthcare provider contacts is a bigger and more important task than ever